期刊文献+

儿童细菌性皮肤病的病原菌分布与耐药性分析 被引量:7

Analysis of the distribution and resistance of bacterial strains isolated from children with bacterial dermatic infection
下载PDF
导出
摘要 目的分析细菌感染性皮肤病住院患儿病原菌分布及耐药性,指导临床合理用药。方法对253例细菌性皮肤病住院患儿进行细菌分离培养,VITEK-AMS60微生物鉴定仪进行病原菌鉴定和药敏试验。结果从253例患儿标本中分离出病原菌216株,其中葡萄球菌211株,占97.7%,A组β-溶血性链球菌(GABHS)5株,占2.3%。葡萄球菌药敏试验结果显示,对氨苄西林/克拉维酸、苯唑西林、头孢唑林、红霉素、环丙沙星和复方磺胺甲噁唑,前3年组(2004—2006年)的耐药率分别为96.6%、94.3%、94.3%、82.8%、21.5%和25.3%,后3年组(2007—2009年)的耐药率分别为97.6%、95.2%、96.8%、91.1%、25.0%和31.5%,各组间差异无统计学意义(P>0.05);但前3年组对克林霉素和庆大霉素的耐药率分别为44.8%和26.4%,后3年组的耐药率分别为81.5%和65.3%,后3年组耐药率高于前3年组(P<0.01和P<0.01);5株GABHS中,4株对红霉素耐药、4株对阿奇霉素耐药,对青霉素、莫匹罗星全部敏感。尚未发现耐万古霉素的菌株。结论葡萄球菌是细菌性皮肤病的主要病原菌;葡萄球菌具有多重耐药性,对克林霉素和庆大霉素的耐药性在增高。 Objective To analyze the distribution and resistance of bacterial strains isolated from hospitalized children with bacterial dermatic infection and guide antibiotics chemotherapy in clinics.Methods Cultures were obtained from 253 hospitalized children with bacterial dermatic infection.Then the bacteria identification and antimicrobial susceptibility were assayed by the VITEK-AMS60.Results 216 strains of pathogens were isolated,including 211 strains of Staphylococcus(97.7%) and 5 strains of Group A β-hemolytic streptococcus(GABHS)(2.3%).The results of antibiotic susceptibility tests on 211 strains of staphylococcus showed that the difference of resistance to ampicillin/clavulanic acid,oxacillin,cefazolin,erythrocin,ciprofloxacin and SMZ/TMP between the strains isolated from the first 3 years(2004-2006) and those isolated from the later 3 years(2007-2009) was insignificant.(96.6% vs 97.6%,P0.05;94.3% vs 95.2%,P0.05;94.3% vs 96.8%,P0.05;82.8% vs 91.1%,P0.05;21.8% vs 25%,P0.05 and 25.3% vs 31.5%,P0.05.).Comparing to the strains isolated from the first 3 years,the strains isolated from the later 3 years have a higher resistant to clindamycin and gentamycin(81.5% vs 44.8%,P0.01 and 65.3% vs 26.4% P0.01).Four out of five GABHS were resistant to erythromycin,azithromycin,and none of the GABHS was resistant to penicillin and mupirocin in this study.None of the isolates was resistant to vancomycin.Conclusion Staphylococcus is the major infective strains in bacterial dermatic infections.These strains of Staphylococcus were multiresistant and the rates of resistance to clindamycin and gentamycin are ascending.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2010年第11期852-854,共3页 Chinese Journal of Antibiotics
基金 国家自然科学基金(30972800)
关键词 皮肤感染 葡萄球菌 耐药性 儿童 Dermatic infection Staphylococcus Resistance Children
  • 相关文献

参考文献9

  • 1周淑华,陈楠.细菌感染性皮肤病[J].中国临床医生杂志,2007,35(10):14-18. 被引量:5
  • 2Bassetti M,Nicco E,Mikulska M.Why is community-associated MRSA spreading across the world and how will it change clinical practice[J].Int J Antimicrob Agents,2009,34(Suppl1):15-19.
  • 3Mark E.Jones,James A.Karlowsky et al Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe:a guide to appropriate antimicrobial therapy[J] ,Int J Antimicrob Agents,2003,22:406-419.
  • 4马琳,赵佩云,杨永弘,袁林,佟月娟.脓疱疮的病原菌分离及耐药性分析[J].中华皮肤科杂志,2000,33(6):389-391. 被引量:31
  • 5Long C B,Madan R P,Herold B C.Diagnosis and management of community-associated MRSA infections in children[J].Expert Rev Anti Infect Ther,2010,8(2):183-195.
  • 6章锐锋,徐志江.社区获得性MRSA感染的临床特征和耐药性分析[J].中华微生物学和免疫学杂志,2004,24(7):573-576. 被引量:29
  • 7Hinckley J,Allen P J.Community-associated MRSA in the pediatric primary care setting[J].Pediatr Nurs.2008,34(1):64-71.
  • 8马越.甲氧西林耐药金黄色葡萄球菌耐药性研究及检测.中国抗生素杂志,2009,34:122-128.
  • 9Parish L C,Parish J L.Retapamulin:A new topical antibiotic for the treatment of uncomplicated skin infections[J].Drugs Today,2008,44(2):91-102.

二级参考文献10

  • 1曾迎红,汤建萍,刘茂生.长沙地区儿童脓疱疮40例病原菌培养及药敏试验[J].湖南医学,1996,13(6):373-373. 被引量:2
  • 2Hartstein AI, Denny MA, Morthland VH, et al. Control of methicillinresistant Staphylococcus aureus in a hospital and an intensive care unit.Infect Control Hosp Epidemiol, 1995, 16(7): 405-411.
  • 3Bukharie HA, Abdelhadi MS, Saeed IA, et al. Emergence of methicillin-resistant Staphylococcus aureus as a community pathogen. Diagn-Microbiol-Infect-Dis, 2001, 40(1): 1-4.
  • 4Livermore DM. Antibiotic resistance in staphylococci. Int J Antimicrob Agents, 2000, 16 (Suppl 1): 3-10.
  • 5Salmenlinna S, Lyytikainen O, Vuopio-Varkila J. Community-acquired methicillin-resistant Staphylococus aureus, Finland. Emerging Infect Dis, 2002, 8(6): 602-607.
  • 6Lencastre H, Matthews PR, Tomasz A, et al. Molecular aspects of methicillin resistance in Staphylococcus aureus. J Antimicrob Chemother,1994, 33(1): 7-24.
  • 7Daum RS, Ito T, Hiramatsu K, et al. A novel methicillin-resistance cassette in community-acquired methicillin-resistant Staphylococcus aureus isolates of diverse genetic backgrounds. J Infect Dis, 2002, 186 (9):1344-1347.
  • 8Almer LS, Shortidge VD, Nilius AM, et al. Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis, 2002, 43(3): 225-232.
  • 9Bartley J. First case of VRSA identified in Michigan. Infect Control Hosp Epidemiol, 2002, 23(8): 480.
  • 10Martinez-Aguilar G, Hammerman WA, Mason EO, et al. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J, 2003, 22(7): 593-598.

共引文献62

同被引文献43

引证文献7

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部